Senate sends Biden military bill that would lift Covid vaccine mandate for troops and authorize more Ukraine funding

Senate sends Biden military bill that would lift Covid vaccine mandate for troops and authorize more Ukraine funding


Preventative Medicine Services NCOIC Sergeant First Class Demetrius Roberson administers a COVID-19 vaccine to a soldier on September 9, 2021 in Fort Knox, Kentucky.

Jon Cherry | Getty Images

The Senate passed a massive military policy bill Thursday that would direct the Defense Department to lift a Covid vaccination mandate for service members and authorize $858 billion in defense spending.

The National Defense Authorization Act, the annual bill that authorizes Pentagon spending and policies, cleared the Senate in an 83-11 vote. Five Republicans and six Democrats opposed the measure.

It passed the House in a 350-80 vote last week.

The legislation now heads to President Joe Biden’s desk for his signature.

The bipartisan bill would authorize funding for Taiwan and Ukraine and a 4.6% pay increase for troops. It also would do away with the military vaccination mandate, a Republican priority. Democratic leaders allowed the new Covid language to ensure timely passage of the bill.

A GOP-backed amendment that pushed for scrapping the vaccination mandate immediately instead of waiting several weeks failed to meet the 60-vote threshold needed for adoption in the Senate.

A separate amendment, offered by Sen. Joe Manchin, D-W.Va., sought to overhaul the process to authorize energy and infrastructure projects, known as permitting reform, in the authorization bill. It also fell short of the 60-vote threshold.



Source

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to  billion
Health

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to $12 billion

A startup widely known as “ChatGPT for doctors” raised a new funding round that values the company at $12 billion. OpenEvidence, based in Miami, Florida, closed a $250 million financing, led by Thrive Capital and DST, the company told CNBC. The startup first raised outside capital in February, when it reeled in $75 million from […]

Read More
Another alliance of health care and AI signals why pharma stocks should be back in favor
Health

Another alliance of health care and AI signals why pharma stocks should be back in favor

Bristol Myers Squibb and Microsoft ‘s new partnership aimed at accelerating early detection of lung cancer marks the latest way health care and artificial intelligence are rapidly intersecting. Bristol Myers said on Tuesday it will work with Microsoft’s AI-powered radiology platform to develop and launch imaging algorithms. These new tools, which can be used to […]

Read More
Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry
Health

Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry

US President Donald Trump arrives for an announcement in the Roosevelt Room of the White House in Washington, DC, US, on Friday, Dec. 19, 2025. Will Oliver | Bloomberg | Getty Images Drug pricing. Looming patent cliffs. Dealmaking. The first year of Trump 2.0. Those are among the themes that dominated conversations last week as drugmakers […]

Read More